Au HCT, Zheng YJ, Le GH, Wong S, Teopiz KM, Kwan ATH, Gill H, Badulescu S, Valentino K, Rosenblat JD, Mansur RB, McIntyre RS (2025) Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic review
u003cstrongu003eCan I microdose Mounjaro daily?u003c/strongu003e No, you should not u003ca href=u0022#microdosing-tirzepatideu0022u003emicrodose Mounjaro (tirzepatide)u003c/au003e daily
Altogether, combination therapy may be reasonable in selected high-risk patients who would benefit from both HF-directed treatment and broader cardiometabolic risk reduction
Stop use and seek medical advice if unexpected symptoms occur
Mitigating factors to explain the lack of performance improvement could be either the use of a CM compound disproportionate to the target ratio of citrulline and malate, or the reliability of the exercise protocol